BIONDVAX
BiondVax Pharmaceuticals, a publicly-traded company (TASE: BNDX) located in the Weizmann Science Park in Ness-Ziona (Israel), is dedicated to the development of a novel Universal Influenza Vaccine. BiondVax's Universal Flu Vaccine is based on research carried out over a period of 20 years by Weizmann Institute Professor Ruth Arnon, who heads the company's Scientific Advisory Board. Professor Arnon is well-known for her part in the development of Copaxoneยฎ, a blockbuster drug for the treatment o... f multiple sclerosis. The Company holds a worldwide exclusive license granted by Yeda Research and Development Ltd., the commercial arm of the Weizmann Institute, Israel, for developing, manufacturing and commercializing this innovative flu vaccine. BiondVaxโs team of 14 includes scientists, technicians, researchers, and administrative staff. The companyโs state-of-the-art GMP facility in Ness-Ziona houses its laboratories, production facilities and offices.
BIONDVAX
Industry:
Biotechnology Health Care Information Technology
Founded:
2003-01-01
Address:
Ness Ziona, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.biondvax.com
Total Employee:
11+
Status:
Active
Contact:
(972) 893-0252
Email Addresses:
[email protected]
Total Funding:
45.49 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Organization Schema Office 365 Mail
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Biocytogen
Biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Peptidream
Peptidream is a biopharmaceutical company.
Sinovant Sciences
Sinovant Sciences is an innovative biopharmaceutical company.
Yisheng Biopharma
Yisheng Biopharma is a global, fully integrated bio-pharmaceutical company.
Current Employees Featured
Founder
Stock Details
Investors List
European Investment Bank
European Investment Bank investment in Post-IPO Debt - BiondVax
Office of the Chief Scientist
Office of the Chief Scientist investment in Grant - BiondVax
Official Site Inspections
http://www.biondvax.com Semrush global rank: 7.47 M Semrush visits lastest month: 481
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013